Table 1.
Demographic characteristics of the patients included.
| Characteristics | Value |
|---|---|
| Patients, No. | 25 |
| Female sex, No. (%) | 23 (92) |
| Age at onset, median (Range), y | 31 (6–55) |
| Duration before receiving tacrolimus, median (Range), mo | 16 (1–98) |
| Duration of tacrolimus, median (Range), mo | 11 (6–34) |
| AQP4-IgG serostatus | |
| AQP4-IgG positivity, No. (%) | 22 (88) |
| Titer of AQP4-IgG <1:64 or none, No. (%) | 14 (56) |
| Titer of AQP4-IgG ≥1:64, No. (%) | 11 (44) |
| Previous immunotherapy, No. (%) | |
| Intravenous immunoglobulin G | 2 (8) |
| Interferon-beta | 1 (4) |
| Plasmapheresis | 2 (8) |
| Azathioprine | 3 (12) |
| Cyclophosphamide | 1 (4) |
| Mycophenolate mofetil | 1 (4) |
AQP4-IgG: aquaporin 4 immunoglobulin G.